Medtronic owns 9% of Salient Surgical, who's business is REALLY picking up now, at an inflection point approaching $100 million in sales. Investors (including MDT) have sunk about $120 million in to Salient. If I was MDT I would think of buying the remaining interest in Salient that they don't already own NOW, before Salient's product becomes really big, or "standard of care" type product. Ah, but then there is BVX. BVX is a threat to the success of Salient, so why not approach BVX too, with the stock THIS cheap, and buy both Salient and BVX. Sooo, MDT tries that, and BVX sez "no way too cheap". So MDT sez "see you in court." and files a ptent suit on 6/8. But BVX would fit perfect with a Salient buyout, since BVX makes generators, which Salient does not. Also, BVX has a key employee, namely Rioux, who would be a great asset to Salient in developing new products. With MDT's marketing muscle behind these two companies, the BOSS, SEER, and Salient's Aquamantys, would really take off. This is all speculation on my part. Maybe MDT pays up for BVX ?